Purple Biotech Ltd. - Capital/Financing Update 2020

Press Release: Kitov Pharma Ltd. Announces Cash Proceeds of $6.5 Million from Exercise of Warrants false


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	20/04/2020
	www.isa.gov.il			www.tase.co.il				Reference:	2020-02-039552	Time of broadcast: 15:14 15:12:42

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onPress Release: Kitov Pharma Ltd. Announces Cash Proceeds of $6.5 Million from Exercise of Warrants

ea120837-pressrelease_042020kitovpharmaDRAFT3_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 18/02/2020
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: [email protected] Company site: www.kitovpharma.com

Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,

Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company: ABZ Law Office
Address: Yad Harutzim 15 , Jerusalem 9342152 Telephone: 079-5722070 Facsimile: 079-5722206 E-mail: [email protected] 1
Israel

AI assistant